Rift MolDx Onco — Acute Leukemia Panel
Real-time PCR product for acute leukemia panel, organized within the Oncology portfolio.
RMD-ONC-001
Rift MolDx
Rift MolDx Oncology.
Molecular assays and NGS panels for hematology and solid-tumour applications.
Full family catalogue
Explore the Oncology portfolio.
Molecular assays and NGS panels for hematology and solid-tumour applications.
Panel Kits
Product groupRift MolDx Onco — ALL Panel
Real-time PCR product for all panel, organized within the Oncology portfolio.
RMD-ONC-002
Rift MolDx Onco — AML Panel
Real-time PCR product for aml panel, organized within the Oncology portfolio.
RMD-ONC-003
Rift MolDx Onco — Leukemia Fusion Panel
Real-time PCR product for leukemia fusion panel, organized within the Oncology portfolio.
RMD-ONC-004
Rift MolDx Onco — MPN Panel
Real-time PCR product for mpn panel, organized within the Oncology portfolio.
RMD-ONC-005
Rift MolDx Onco — Paediatric Leukemia Panel
Real-time PCR product for paediatric leukemia panel, organized within the Oncology portfolio.
RMD-ONC-006
Rift MolDx Onco — Colorectal Cancer Mutation Panel
Real-time PCR product for colorectal cancer mutation panel, organized within the Oncology portfolio.
RMD-ONC-007
Individual Markers
Product groupRift MolDx Onco — C-KIT Mutation Detection Kit
Real-time PCR product for c-kit mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-008
Rift MolDx Onco — CALR Mutation Detection Kit
Real-time PCR product for calr mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-009
Rift MolDx Onco — CXCR4 Mutation Detection Kit
Real-time PCR product for cxcr4 mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-010
Rift MolDx Onco — DPYD Mutation Detection Kit
Real-time PCR product for dpyd mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-011
Rift MolDx Onco — FLT3 Mutation Detection Kit
Real-time PCR product for flt3 mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-012
Rift MolDx Onco — JAK2 Qualitative Mutation Detection Kit
Real-time PCR product for jak2 qualitative mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-013
Rift MolDx Onco — JAK2 Quantitative Allele-Burden Kit
Real-time PCR product for jak2 quantitative allele-burden kit, organized within the Oncology portfolio.
RMD-ONC-014
Rift MolDx Onco — MYD88 Mutation Detection Kit
Real-time PCR product for myd88 mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-015
Rift MolDx Onco — NPM1 Quantitative Mutation Kit
Real-time PCR product for npm1 quantitative mutation kit, organized within the Oncology portfolio.
RMD-ONC-016
Rift MolDx Onco — NPM1 Qualitative Mutation Detection Kit
Real-time PCR product for npm1 qualitative mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-017
Rift MolDx Onco — PML-RARA Qualitative Kit
Real-time PCR product for pml-rara qualitative kit, organized within the Oncology portfolio.
RMD-ONC-018
Rift MolDx Onco — PML-RARA Quantitative Kit
Real-time PCR product for pml-rara quantitative kit, organized within the Oncology portfolio.
RMD-ONC-019
Rift MolDx Onco — IDH1/2 Detection & Differentiation Kit
Real-time PCR product for idh1/2 detection & differentiation kit, organized within the Oncology portfolio.
RMD-ONC-020
Rift MolDx Onco — IDH1/2 Mutation Detection Kit
Real-time PCR product for idh1/2 mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-021
Rift MolDx Onco — MPL Mutation Detection Kit
Real-time PCR product for mpl mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-022
Rift MolDx Onco — TPMT Mutation Detection Kit
Real-time PCR product for tpmt mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-023
BCR-ABL1
Product groupRift MolDx Onco — BCR-ABL1 b2a2/b3a2 Differentiation Kit
RT-qPCR product for bcr-abl1 b2a2/b3a2 differentiation kit, organized within the Oncology portfolio.
RMD-ONC-024
Rift MolDx Onco — BCR-ABL1 Qualitative Kit
RT-qPCR product for bcr-abl1 qualitative kit, organized within the Oncology portfolio.
RMD-ONC-025
Rift MolDx Onco — BCR-ABL1 Quantitative Kit
RT-qPCR product for bcr-abl1 quantitative kit, organized within the Oncology portfolio.
RMD-ONC-026
Rift MolDx Onco — BCR-ABL1 Transcript Screening Kit
RT-qPCR product for bcr-abl1 transcript screening kit, organized within the Oncology portfolio.
RMD-ONC-027
Solid-Tumour Markers
Product groupRift MolDx Onco — BRAF Mutation Detection Kit
Real-time PCR product for braf mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-028
Rift MolDx Onco — EGFR Mutation Detection Kit
Real-time PCR product for egfr mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-029
Rift MolDx Onco — KRAS Mutation Detection Kit
Real-time PCR product for kras mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-030
Rift MolDx Onco — MGMT Methylation Detection Kit
Real-time PCR product for mgmt methylation detection kit, organized within the Oncology portfolio.
RMD-ONC-031
Rift MolDx Onco — NRAS Mutation Detection Kit
Real-time PCR product for nras mutation detection kit, organized within the Oncology portfolio.
RMD-ONC-032
Rift MolDx Onco — ROS1 Fusion Detection Kit
Real-time PCR product for ros1 fusion detection kit, organized within the Oncology portfolio.
RMD-ONC-033
Rift MolDx Onco — ALK Fusion Detection Kit
Real-time PCR product for alk fusion detection kit, organized within the Oncology portfolio.
RMD-ONC-034
NGS Panel Kits
Product groupRift MolDx Onco — BRCA Plus Panel
NGS product for brca plus panel, organized within the Oncology portfolio.
RG-ONC-035
Rift MolDx Onco — Endometrial Cancer Panel
NGS product for endometrial cancer panel, organized within the Oncology portfolio.
RG-ONC-036
Rift MolDx Onco — Pan-Myeloid Panel
NGS product for pan-myeloid panel, organized within the Oncology portfolio.
RG-ONC-037
Rift MolDx Onco — Solid Tumour Panel
NGS product for solid tumour panel, organized within the Oncology portfolio.
RG-ONC-038
Product-detail panels use Rift naming and Rift catalogue identifiers. Final packaging configuration and market-specific regulatory status should be confirmed before publication.